Essilor : H1 2018 largely as expected. Unchanged guidance but China has approved the link-up with Luxottica which is set to be official by end-2018!
>Q2 2018 sales +4.8% l-f-l, +0.2% acquisitions, 1% shy of forecasts - Essilor has reported Q2 2018 sales (€ 1.901bn, +4.8% l-f-l, +0.2% acquisitions), 1% shy of consensus forecasts and H1 underlying operating profit (€ 684m, margin of 18.4%, -20bp) 1% below estimates.Q2 2018 sales by division: Lenses and optical instruments (€ 1.619bn, 4.2% l-f-l, 0.2% acquisitions) fell 2% short of our expectations // Equipment (€ 59m, 4.2% l-f-l, 0% acquisitions) matched our ex...Essilor International (Compagnie Generale d'Optique) designs, manufactures and sells ophthalmic lenses, ophthalmic optical instruments and equipment. Co.'s activities are divided into three segments: Lenses and Optical Instruments (Co. designs, manufactures and customizes corrective lenses such as: Varilux (progressive lenses); anti-reflective, smudge-proof and anti-static lenses (Crizal); Nikon lenses, Transitions variable-tint lenses and Kodak lenses under agreements; polarized lenses (Xperio) and fog-proof lenses (Optifog)), Equipment (Co. produces, distributes and sells equipment and consumables used by prescription laboratories) and Readers (Co. designs and sells reading glasses).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.